L. A. Times Dodgers Blog (Free subscription) | 11/05/2009
... give when dispensing prescriptions.Examining patient information is long overdue, said Dr. Sidney Wolfe, director of the health research group Public Citizen, a nonprofit consumer advocacy group."About 99.5% of pamphlets are completely unregulated," Wolfe said. "They are missing critical information."The FDA also recommended ways to reduce dosage errors in liquid medications,...
Piece Of Mind (Free subscription) | 10/25/2009
... of facilities, treatments and doctors than traditional Medicare offers. Drs. David Himmelstein and Sidney Wolfe talked about the private Medicare option on the Bill Moyers Journal back in May : Himmelstein :…the private insurers have all kinds of tricks to avoid sick patients, who are the expensive patients. So, you put your signup office on the second floor of a walkup building....
online pharmacy store (Free subscription) | 10/20/2009
... boss’s drug look good. The Celebrex case isn’t an aberration, according to Public Citizen’s Dr. Sidney Wolfe. “People are injured and killed as a result of incomplete data being published and studies being designed in the wrong ways,” he says. Corporate researchers attempt to prove marketing claims, not insure public health, critics say, so results are buffed or buried even if it...
Miami Herald (Free subscription) | 10/02/2009
... the health dangers in marketing a drug for an unapproved use, called off-label promotion, said Sidney Wolfe, head of the health research group at Public Citizen in Washington.•FDA OK's Allergan's eyelash drugAllergan, which manufactures Botox, has received U.S. approval to sell the first prescription medicine to make eyelashes longer, darker and thicker.The Food and Drug Administration...
Miami Herald (Free subscription) | 10/02/2009
... the health dangers in marketing a drug for an unapproved use, called off-label promotion, said Sidney Wolfe, head of the health research group at Public Citizen in Washington.•FDA OK's Allergan's eyelash drugAllergan, which manufactures Botox, has received U.S. approval to sell the first prescription medicine to make eyelashes longer, darker and thicker.The Food and Drug Administration...
